Human Genome Sciences Inc. (HGSI) Readies for Lupus Testing Results After Phase III Completion
Some investors often wonder why others have come out of the latest economic conditions with a better looking portfolio then theirs. Yes, there are very few investors that found no hit to their portfolio or made a profit as a result of current conditions, but there are those that were less affected. Why? In past posts the philosophy of looking past the next quarter has been a common theme. One quarter or event does not make a poorly performing company if the company has a solid product mix and executes correctly. An investor that can look past a bump or…